SCHEMBL3277265

SCHEMBL3277265

CCOC(=O)CNCc1c(C(=O)OCC)n(Cc2cccc3ccc(F)cc23)c2ccc(F)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 3/20 0.42
HK1 P19367 2/20 0.42
HKDC1 Q2TB90 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PTGDR2 Q9Y5Y4 4/20 0.41
TP53 P04637 4/20 0.40
ELANE P08246 1/20 0.39
POLB P06746 2/20 0.38
MAPT P10636 5/20 0.37
KDM4E B2RXH2 2/20 0.36
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PKM P14618 1/20 0.36
PTGIR P43119 1/20 0.36
PTGDR Q13258 1/20 0.36
HASPIN Q8TF76 1/20 0.36
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3275175 0.96 MEN1 (0.47) MEN1KMT2AALDH1A1HK1HKDC1
SCHEMBL3277568 0.96 MEN1 (0.45) MEN1KMT2AALDH1A1HK1HKDC1
SCHEMBL3281145 0.95 MEN1 (0.51) MEN1KMT2AALDH1A1HK1HKDC1
SCHEMBL3277161 0.93 TP53 (0.47) ALDH1A1HK1HKDC1SMN1; SMN2PTGDR2
SCHEMBL3281129 0.91 MEN1 (0.47) MEN1KMT2AALDH1A1HK1HKDC1
SCHEMBL3275053 0.91 MEN1 (0.50) MEN1KMT2AALDH1A1PTGDR2TP53
SCHEMBL3276383 0.89 POLB (0.49) MEN1KMT2AALDH1A1HK1HKDC1
SCHEMBL3277706 0.89 MEN1 (0.45) MEN1KMT2AALDH1A1HK1HKDC1
SCHEMBL3277403 0.88 MEN1 (0.47) MEN1KMT2AALDH1A1HK1HKDC1
SCHEMBL3275723 0.88 POLB (0.53) MEN1KMT2ATP53POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966134-B1 NOVEL FUSED PYRROLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142452-A1 Fused pyrrole derivatives CMA1, PREP, CPA3 MEN1 2461/4885KMT2A 3786/4885ALDH1A1 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.